[Transarterial hepatic embolization of metastatic liver cancers with reference to 17 cases of survival for more than 2 years].
The evaluation of TAE was studied for 73 patients with metastatic liver cancers but without metastasis in other organs, who were treated with initial TAE more than 2 years ago. Seventeen patients survived for more than 2 years. The primary lesions consisted of colon cancer in 9 patients, the Langerhans islet cell tumor of the pancreas in 4, gastric cancers in 2, breast cancer in 1 and leiomyosarcoma of the colon in 1. The overall 2-year survival rate calculated by the direct method was 23.3% and mean survival period was 15.8 months. The prognosis was good in H1 and V3. Lp-TAE produced better effects but no statistically significant difference was found between the 2-year survivals by Lp-TAE and by GS-TAE.
Satoh
O
O
Department of Radiology, Nara Medical University.
Sakaguchi
H
H
Yoshioka
T
T
Nagano
N
N
Nakagawa
H
H
Yoshimura
Y
Y
Ohishi
H
H
Uchida
H
H
Tsushima
J
J
Ohue
S
S
D000328:Adult; D000368:Aged; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000556:secondary* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D015996:Survival Rate